-
1
-
-
0035056817
-
Contemporary management of chronic stable angina
-
Staniforth AD. Contemporary management of chronic stable angina. Drugs Aging. 2001;18:109-121.
-
(2001)
Drugs Aging
, vol.18
, pp. 109-121
-
-
Staniforth, A.D.1
-
2
-
-
0028025629
-
Characteristics of a contemporary population with angina pectoris
-
Pepine CJ, Abrams J, Marks RG, Morris JJ, Scheldt SS, Handberg E. Characteristics of a contemporary population with angina pectoris. Am J Cardiol. 1994;74:226-231.
-
(1994)
Am J Cardiol
, vol.74
, pp. 226-231
-
-
Pepine, C.J.1
Abrams, J.2
Marks, R.G.3
Morris, J.J.4
Scheldt, S.S.5
Handberg, E.6
-
3
-
-
0035217109
-
A double-blind, parallel-group study of amlodipine versus long-acting nitrate in the management of elderly patients with stable angina
-
Hall R, Chong C. A double-blind, parallel-group study of amlodipine versus long-acting nitrate in the management of elderly patients with stable angina. Cardiology. 2001;96:72-77.
-
(2001)
Cardiology
, vol.96
, pp. 72-77
-
-
Hall, R.1
Chong, C.2
-
4
-
-
0028365339
-
Phenomenon of nitrate tolerance
-
Mangione NJ, Glasser SP. Phenomenon of nitrate tolerance. Am Heart J. 1994;128:137-146.
-
(1994)
Am Heart J
, vol.128
, pp. 137-146
-
-
Mangione, N.J.1
Glasser, S.P.2
-
5
-
-
0037012370
-
The effect of supplemental L-arginine on tolerance development during continuous transdermal nitroglycerin therapy
-
Parker JO, Parker JD, Caldwell RW, Farrell B, Kaesemeyer WH. The effect of supplemental L-arginine on tolerance development during continuous transdermal nitroglycerin therapy. J Am Coll Cardiol. 2002;39:1199-1203.
-
(2002)
J Am Coll Cardiol
, vol.39
, pp. 1199-1203
-
-
Parker, J.O.1
Parker, J.D.2
Caldwell, R.W.3
Farrell, B.4
Kaesemeyer, W.H.5
-
6
-
-
11144354818
-
Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance
-
Sydow K, Daiber A, Oelze M, et al. Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance. J Clin Invest. 2004;113:482-489.
-
(2004)
J Clin Invest
, vol.113
, pp. 482-489
-
-
Sydow, K.1
Daiber, A.2
Oelze, M.3
-
7
-
-
4143128926
-
Contemporary management of silent ischemia: The role of ambulatory monitoring
-
Solomon H, DeBusk RF. Contemporary management of silent ischemia: the role of ambulatory monitoring. Int J Cardiol. 2004;96:311-319.
-
(2004)
Int J Cardiol
, vol.96
, pp. 311-319
-
-
Solomon, H.1
DeBusk, R.F.2
-
8
-
-
0031821277
-
Clinical pharmacokinetics of vasodilators, Part II
-
Kirsten R, Nelson K, Kirsten D, Heintz B. Clinical pharmacokinetics of vasodilators, Part II. Clin Pharmacokinet. 1998;35:9-36.
-
(1998)
Clin Pharmacokinet
, vol.35
, pp. 9-36
-
-
Kirsten, R.1
Nelson, K.2
Kirsten, D.3
Heintz, B.4
-
9
-
-
0028103963
-
Coronary dilatation after intracoronary administration of SIN-1 and intravenous molsidomine administration
-
Hug J, Hasenfuss G, Wollschlager H, Just HJ, Bonzel T. Coronary dilatation after intracoronary administration of SIN-1 and intravenous molsidomine administration. Med Klin. 1994;89(suppl 2):34-37.
-
(1994)
Med Klin
, vol.89
, Issue.SUPPL. 2
, pp. 34-37
-
-
Hug, J.1
Hasenfuss, G.2
Wollschlager, H.3
Just, H.J.4
Bonzel, T.5
-
10
-
-
0028132726
-
Effects of intravenous administration of nitroglycerin and SIN-1 or molsidomine on epicardial arterial diameter in patients with stable coronary heart disease
-
Münzel T, Kurz S, Heitzer T, Luhmann C, Just HJ. Effects of intravenous administration of nitroglycerin and SIN-1 or molsidomine on epicardial arterial diameter in patients with stable coronary heart disease. Med Klin. 1994;89(suppl 2):38-41.
-
(1994)
Med Klin
, vol.89
, Issue.SUPPL. 2
, pp. 38-41
-
-
Münzel, T.1
Kurz, S.2
Heitzer, T.3
Luhmann, C.4
Just, H.J.5
-
12
-
-
0023505509
-
Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide
-
Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA. 1987;84:9265-9269.
-
(1987)
Proc Natl Acad Sci USA
, vol.84
, pp. 9265-9269
-
-
Ignarro, L.J.1
Buga, G.M.2
Wood, K.S.3
Byrns, R.E.4
Chaudhuri, G.5
-
14
-
-
0024799327
-
Molsidomine is a donor of EDRF
-
Vanhoutte PM. Molsidomine is a donor of EDRF. J Cardiovasc Pharmacol. 1989;14(suppl 11):S139-S140.
-
(1989)
J Cardiovasc Pharmacol
, vol.14
, Issue.SUPPL. 11
-
-
Vanhoutte, P.M.1
-
15
-
-
0027458533
-
SIN-1 reduces platelet adhesion and platelet thrombus formation in a porcine model of balloon angioplasty
-
Groves PH, Lewis MJ, Cheadle HA, Penny WJ. SIN-1 reduces platelet adhesion and platelet thrombus formation in a porcine model of balloon angioplasty. Circulation. 1993;87:590-597.
-
(1993)
Circulation
, vol.87
, pp. 590-597
-
-
Groves, P.H.1
Lewis, M.J.2
Cheadle, H.A.3
Penny, W.J.4
-
16
-
-
0034059722
-
2+ handling in patients with suspected coronary artery disease: Ex vivo and in vitro studies
-
2+ handling in patients with suspected coronary artery disease: ex vivo and in vitro studies. Thromb Haemost. 2000;83:752-758.
-
(2000)
Thromb Haemost
, vol.83
, pp. 752-758
-
-
Le Quan Sang, K.H.1
Le Feuvre, C.2
Brunet, A.3
-
17
-
-
0022196041
-
Exercise tolerance in coronary patients: Randomized trial of two-week treatment with molsidomine versus placebo
-
Messin R. Exercise tolerance in coronary patients: randomized trial of two-week treatment with molsidomine versus placebo. Am Heart J. 1985;109:667-669.
-
(1985)
Am Heart J
, vol.109
, pp. 667-669
-
-
Messin, R.1
-
18
-
-
0028919862
-
Acute and chronic effect of molsidomine extended release on exercise capacity in patients with stable angina: A double-blind cross-over clinical trial versus placebo
-
Messin R, Boxho G, De Smedt J, Buntinx IM. Acute and chronic effect of molsidomine extended release on exercise capacity in patients with stable angina: a double-blind cross-over clinical trial versus placebo. J Cardiovasc Pharmacol. 1995;25:558-563.
-
(1995)
J Cardiovasc Pharmacol
, vol.25
, pp. 558-563
-
-
Messin, R.1
Boxho, G.2
De Smedt, J.3
Buntinx, I.M.4
-
19
-
-
0031911443
-
Short- and long-term effects of molsidomine retard and molsidomine nonretard on exercise capacity and clinical status in patients with stable angina: A multicenter randomized double-blind crossover placebo-controlled trial
-
Messin R, Karpov Y, Baikova N, et al. Short- and long-term effects of molsidomine retard and molsidomine nonretard on exercise capacity and clinical status in patients with stable angina: a multicenter randomized double-blind crossover placebo-controlled trial. J Cardiovasc Pharmacol. 1998;31:271-276.
-
(1998)
J Cardiovasc Pharmacol
, vol.31
, pp. 271-276
-
-
Messin, R.1
Karpov, Y.2
Baikova, N.3
-
21
-
-
0021680630
-
Effect duration and dose-response relation of molsidomine in patients with coronary heart disease
-
Fach WA, Becker HJ. Effect duration and dose-response relation of molsidomine in patients with coronary heart disease. Z Kardiol. 1984;73:613-622.
-
(1984)
Z Kardiol
, vol.73
, pp. 613-622
-
-
Fach, W.A.1
Becker, H.J.2
-
22
-
-
0030152638
-
Modulation of the dissolution profiles from Geomatrix multi-layer matrix tablets containing drugs of different solubility
-
Conte U, Maggi L. Modulation of the dissolution profiles from Geomatrix multi-layer matrix tablets containing drugs of different solubility. Biomaterials. 1996;17:889-896.
-
(1996)
Biomaterials
, vol.17
, pp. 889-896
-
-
Conte, U.1
Maggi, L.2
-
23
-
-
0033952741
-
High molecular weight polyethylene oxides (PEOs) as an alternative to HPMC in controlled release dosage forms
-
Maggi L, Bruni R, Conte U. High molecular weight polyethylene oxides (PEOs) as an alternative to HPMC in controlled release dosage forms. Int J Pharm. 2000;195:229-238.
-
(2000)
Int J Pharm
, vol.195
, pp. 229-238
-
-
Maggi, L.1
Bruni, R.2
Conte, U.3
-
24
-
-
3242802152
-
Clinical pharmacokinetics of once-daily molsidomine: From immediate-release to prolonged-release once-daily formulations
-
Herchuelz A, Carreer-Bruhwyler F, Crommen J, et al. Clinical pharmacokinetics of once-daily molsidomine: from immediate-release to prolonged-release once-daily formulations. Am J Drug Deliv. 2004;131-141.
-
(2004)
Am J Drug Deliv
, pp. 131-141
-
-
Herchuelz, A.1
Carreer-Bruhwyler, F.2
Crommen, J.3
-
25
-
-
0031726089
-
A comparative study of once-daily amlodipine versus twice-daily diltiazem controlled release (CR) in the treatment of stable angina pectoris
-
van Kesteren HA, Withagen AJ. A comparative study of once-daily amlodipine versus twice-daily diltiazem controlled release (CR) in the treatment of stable angina pectoris. Cardiovasc Drugs Ther. 1998;12(suppl 3):233-237.
-
(1998)
Cardiovasc Drugs Ther
, vol.12
, Issue.SUPPL. 3
, pp. 233-237
-
-
Van Kesteren, H.A.1
Withagen, A.J.2
-
26
-
-
0033639013
-
Factors influencing efficacy of nitrate therapy for stable angina pectoris: A multiple linear regression analysis
-
Jansen R, Niemeyer MG, Cleophas TJ, Zwinderman AH. Factors influencing efficacy of nitrate therapy for stable angina pectoris: a multiple linear regression analysis. Angiology. 2000;51:1007-1012.
-
(2000)
Angiology
, vol.51
, pp. 1007-1012
-
-
Jansen, R.1
Niemeyer, M.G.2
Cleophas, T.J.3
Zwinderman, A.H.4
-
27
-
-
0034882896
-
A randomized, double-blind comparison of the efficacy and tolerability of once-daily modified-release diltiazem capsules with once-daily amlodipine tablets in patients with stable angina
-
Chugh SK, Digpal K, Hutchinson T, McDonald CJ, Miller AJ, Lahiri A. A randomized, double-blind comparison of the efficacy and tolerability of once-daily modified-release diltiazem capsules with once-daily amlodipine tablets in patients with stable angina. J Cardiovasc Pharmacol. 2001;38:356-364.
-
(2001)
J Cardiovasc Pharmacol
, vol.38
, pp. 356-364
-
-
Chugh, S.K.1
Digpal, K.2
Hutchinson, T.3
McDonald, C.J.4
Miller, A.J.5
Lahiri, A.6
-
28
-
-
0035094582
-
Testing the effectiveness of converting patients to long-acting antianginal medications: The Quality of Life in Angina Research Trial (QUART)
-
Spertus JA, Dewhurst T, Dougherty CM, Nichol P. Testing the effectiveness of converting patients to long-acting antianginal medications: the Quality of Life in Angina Research Trial (QUART). Am Heart J. 2001;141:550-558.
-
(2001)
Am Heart J
, vol.141
, pp. 550-558
-
-
Spertus, J.A.1
Dewhurst, T.2
Dougherty, C.M.3
Nichol, P.4
-
29
-
-
0015058704
-
Importance of the design of an exercise protocol in the evaluation of patients with angina pectoris
-
Redwood DR, Rosing DR, Goldstein RE, Beiser GD, Epstein SE. Importance of the design of an exercise protocol in the evaluation of patients with angina pectoris. Circulation. 1971;43:618-628.
-
(1971)
Circulation
, vol.43
, pp. 618-628
-
-
Redwood, D.R.1
Rosing, D.R.2
Goldstein, R.E.3
Beiser, G.D.4
Epstein, S.E.5
-
31
-
-
0024294261
-
Direct medical costs of disease and gastrointestinal side effects during treatment for arthritis
-
Bloom BS. Direct medical costs of disease and gastrointestinal side effects during treatment for arthritis. Am J Med. 1988;84(suppl 2A):20-24.
-
(1988)
Am J Med
, vol.84
, Issue.SUPPL. 2A
, pp. 20-24
-
-
Bloom, B.S.1
-
32
-
-
0031659477
-
Continuation of initial antihypertensive medication after 1 year of therapy
-
Bloom BS. Continuation of initial antihypertensive medication after 1 year of therapy. Clin Ther. 1998;20:1-11.
-
(1998)
Clin Ther
, vol.20
, pp. 1-11
-
-
Bloom, B.S.1
-
33
-
-
0035934617
-
Daily regimen and compliance with treatment
-
Bloom BS. Daily regimen and compliance with treatment. BMJ. 2001;323:647.
-
(2001)
BMJ
, vol.323
, pp. 647
-
-
Bloom, B.S.1
|